Post-approval studies (Phase 4)Study completedNCT01497652
What this trial is testing
A Double Blind Placebo Controlled Trial Evaluating Rasagiline Effects on Cognition in Parkinson's Disease Patients With Mild Cognitive Impairment Receiving Dopaminergic Therapy
Who this might be right for
Parkinson's Disease
Georgetown University 34